Submitted by Anonymous (not verified) on 19 May 2026 - 12:30
Human medicines European public assessment report (EPAR): Spexotras, trametinib, Date of authorisation: 05/01/2024, Revision: 10, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Spexotras, trametinib, Date of authorisation: 05/01/2024, Revision: 10, Status: Authorised